Tocqueville Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Tocqueville Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-258,150	Closed	-$1.58M	–	842
2017 Q3	$1.58M	Hold	258,150	–	–	0.02%	475
2017 Q2	$1.87M	Buy	258,150 +8,150	+3%	+$50.1K	0.02%	433
2017 Q1	$1.32M	Buy	250,000 +90,000	+56%	+$608K	0.02%	460
2016 Q4	$1.15M	Buy	160,000 +110,000	+220%	+$889K	0.01%	478
2016 Q3	$468K	Buy	50,000 +17,000	+52%	+$141K	0.01%	643
2016 Q2	$209K	Buy	+33,000	New	+$212K	﹤0.01%	789
2015 Q4	–	Sell	-37,000	Closed	-$313K	–	975
2015 Q3	$313K	Buy	+37,000	New	+$626K	﹤0.01%	801

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Tocqueville Asset Management's PETX Position: Q4 2017 in Review

Tocqueville Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2017, closing a stake of 258,150 shares — an estimated $1.58M sold.

Tocqueville Asset Management first reported a position in PETX in Q3 2015 and held it in 7 quarters. The position peaked at $1.87M in Q2 2017. 105 funds tracked by Wall St. Rank hold PETX as of Q4 2017.

Tocqueville Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Tocqueville Asset Management sold 258,150 Aratana Therapeutics, Inc. shares in Q4 2017, an estimated $1.58M.
Tocqueville Asset Management first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 7 quarters.
Tocqueville Asset Management's Aratana Therapeutics, Inc. position peaked at $1.87M in Q2 2017.
105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2017.

Based on Tocqueville Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.